BOOSTRIX is indicated for active booster immunization against tetanus, diphtheria, and pertussis in individuals aged 10 years and older.
Severe allergic reaction after a previous dose of any tetanus toxoid-, diphtheria toxoid-, or pertussis antigen-containing vaccine, or to any component of BOOSTRIX, or encephalopathy within 7 days of a previous pertussis antigen-containing vaccine is a contraindication.
*Tetanus, diphtheria, and acellular pertussis.
†U.S. Food and Drug Administration
Adacel is a registered trademark of Sanofi Pasteur group, and its subsidiaries.